[Glibenclamid-HB 419: clinical testing of a new antidiabetic].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D005500:Follow-Up Studies; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010919:Placebos
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010919:Placebos; D005905:Glyburide
Glibenclamid-HB 419: klinisk prövning av nytt antidiabetikum.